<DOC>
	<DOCNO>NCT02843984</DOCNO>
	<brief_summary>Objective : To evaluate influence vaginal Lactoferrin administration amniotic fluid concentration 47 cytokine , chemokines growth factor .</brief_summary>
	<brief_title>Influence Vaginal Lactoferrin Amniotic Fluid Cytokines Avoid Pregnancy Complications</brief_title>
	<detailed_description>60 woman undergoing genetic amniocentesis enrol Obstetric Unit , University Ferrara . The selected patient randomly assign receive 300 mg vaginal Lactoferrin obtain 3 group : A , 20 untreated patient ; B C ( 20 patient one ) respectively treat 4 12 h amniocentesis . Cytokines , chemokines growth factor concentration quantify magnetic bead Luminex multiplex immunoassays panel technology . Amniotic fluid sample obtain transabdominal amniocentesis sample required clinical purpose centrifuge remove particulate material supernatant aliquoted stored -80Â°C assay .</detailed_description>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>singleton physiological pregnancy ; maternal age indication foetal karyotyping assumption drug interfere immune system ; previous miscarriage ; pregnancy risk maternal foetal disease ; lactose intolerance .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Amniocentesis</keyword>
</DOC>